MedMen Enterprises
Financial ratios & Valuation

Historical Multiples (2012 – 2022)

2012 2013 2014 2016 2017 2018 2019 2020 2021 2022 TTM Median
Valuation Ratios
Price/Earnings ratio
-3.63-6.75-6.08-15.96-0.12-1.19-1.03-0.12-0.92-0.42-0.15-1.19
Price/Sales ratio
36.4240.1952.1298.740.743.372.210.390.920.490.153.37
Price/Book Value ratio
-2.19-436.853.8410.340.051.221.220.380.700.460.130.05
Price/Cash Flow ratio
-8.55-5.78-15.81-18.52-0.10-1.95-1.22-0.55-2.25-1.11-0.94-1.95
Price/Free Cash Flow ratio
-8.55-5.78-15.81-18.52-0.06-1.04-0.79-0.36-1.99-0.96-0.68-1.04
Price/Earnings Growth ratio
0.070.14-0.500.25-0.000.010.190.000.010.00-0.000.01
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
68.77%61.45%71.27%60.69%32.49%34.81%46.84%36.99%46.38%49.51%50.22%32.49%
Operating Profit Margin
-882.08%-582.99%-856.01%-618.02%-553.53%-242.82%-171.04%-122.68%-61.55%-43.53%-102.71%-553.53%
Pretax Profit Margin
-1002.74%-594.89%-856.01%-618.69%-575.45%-278.32%-202.54%-328.01%-98.99%-124.59%-124.28%-575.45%
Net Profit Margin
-1002.74%-594.89%-856.01%-618.69%-577.07%-282.19%-213.17%-302.80%-100.26%-117.57%-103.68%-577.07%
Effective Tax Rate
N/AN/AN/AN/A-0.28%-1.39%-5.24%7.68%-1.27%5.64%11.42%-0.28%
Return on Assets
-859.94%-331.59%-61.29%-61.87%-25.51%-39.78%-43.65%-82.84%-30.78%-51.21%-55.71%-39.78%
Return On Equity
60.46%6465.34%-63.15%-64.84%-45.91%-102.44%-117.36%-297.54%-75.84%-109.05%-80.00%-80.00%
Return on Capital Employed
53.18%6337.43%-63.15%-64.77%-31.97%-48.11%-42.77%-50.05%-48.57%1919.62%-15847.93%-48.11%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.42N/A
Quick Ratio
0.060.9533.9221.830.941.290.750.320.260.460.131.29
Cash ratio
0.010.1531.6520.750.400.970.290.050.040.030.060.97
Days of Sales Outstanding
319.00547.45212.8438.45300.3635.1143.7821.6722.979.8748.1748.17
Days of Inventory outstanding
N/AN/AN/A9.0846.8087.94154.1483.4794.2951.4078.2546.80
Operating Cycle
319.00547.45212.8447.53347.16123.06197.93105.14117.2661.2790.13123.06
Days of Payables Outstanding
2.43K1.78K523.07424.70198.1050.85263.07293.24164.55105.24112.5150.85
Cash Conversion Cycle
-2.11K-1.23K-310.23-377.17149.0572.20-65.14-188.10-47.28-43.96-45.0472.20
Debt Ratios
Debt Ratio
N/AN/AN/AN/A0.310.190.450.931.051.222.370.31
Debt Equity Ratio
N/AN/AN/AN/A0.570.511.213.352.602.603.870.57
Long-term Debt to Capitalization
N/AN/AN/AN/A0.270.030.520.760.660.640.660.27
Total Debt to Capitalization
N/AN/AN/AN/A0.360.330.540.770.720.720.710.36
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-3.59N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/A-0.94-1.23-0.82-0.20-0.11-0.15-0.05-0.94
Company Equity Multiplier
-0.07-19.491.031.041.792.572.683.592.462.121.622.57
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.25-6.95-3.29-5.33-6.79-1.73-1.81-0.70-0.41-0.44-0.16-6.79
Free Cash Flow / Operating Cash Flow Ratio
11111.561.861.541.551.131.151.371.86
Cash Flow Coverage Ratio
N/AN/AN/AN/A-0.94-1.23-0.82-0.20-0.11-0.15-0.05-0.94
Short Term Coverage Ratio
N/AN/AN/AN/A-2.75-1.31-10.38-3.99-0.52-0.52-0.25-2.75
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A